Tc Biopharm (holdings) PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
TC BioPharm (Holdings) plc is convening its 2024 Annual General Meeting (AGM) on July 1, 2024, seeking shareholder approval for several resolutions, including the potential issuance of securities in non-public offerings to raise capital.